Etiologic classification of attention-deficit/hyperactivity disorder

被引:134
作者
Millichap, J. Gordon [1 ]
机构
[1] Northwestern Univ, Sch Med, Childrens Mem Hosp, Div Neurol, Chicago, IL 60614 USA
关键词
attention deficit; hyperactivity; etiology; environmental; viral; nicotine; thyroid;
D O I
10.1542/peds.2007-1332
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Attention-deficit/hyperactivity disorder is a neurobiological syndrome with an estimated prevalence among children and adolescents of 5%. It is a highly heritable disorder, but acquired factors in etiology are sometimes uncovered that may be amenable to preventive measures or specific therapy. Early reports have described symptoms similar to attention-deficit/hyperactivity disorder that followed brain trauma or viral encephalitis, and recent MRI studies have demonstrated brain volumetric changes that may be involved in the pathophysiology of the syndrome. The American Psychiatric Association's Diagnostic Statistical Manual, introduced in 1968, emphasizes symptomatic criteria in diagnosis. Here, an overview of environmental factors in the etiology of attention-deficit/hyperactivity disorder is presented to encourage more emphasis and research on organic causal factors, preventive intervention, and specific therapies. An organic theory and the genetic and biochemical basis of attention-deficit/hyperactivity disorder are briefly reviewed, and an etiologic classification is suggested. Environmental factors are prenatal, perinatal, and postnatal in origin. Pregnancy- and birth-related risk factors include maternal smoking and alcohol ingestion, prematurity, hypoxic-ischemic encephalopathy, and thyroid deficiency. Childhood illnesses associated with attention-deficit/hyperactivity disorder include virus infections, meningitis, encephalitis, head injury, epilepsy, toxins, and drugs. More controversial factors discussed are diet-related sensitivities and iron deficiency. Early prenatal recognition, prevention, and treatment of environmental etiologies of attention-deficit/hyperactivity disorder may reduce physician reliance on symptomatic modification with medication, a frequent reason for parental concern.
引用
收藏
页码:E358 / E365
页数:8
相关论文
共 69 条
[1]  
ADESMAN A R, 1990, Pediatrics, V85, P442
[2]   Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371] [J].
Akhondzadeh, Shahin ;
Mohammadi, Mohammad-Reza ;
Khademi, Mojgan .
BMC PSYCHIATRY, 2004, 4 (1)
[3]  
[Anonymous], INT PEDIAT
[4]   Zinc in attention-deficit/hyperactivity disorder [J].
Arnold, LE ;
DiSilvestro, RA .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (04) :619-627
[5]   Serum zinc correlates with parent- and teacher-rated inattention in children with attention-deficit/hyperactivity disorder [J].
Arnold, LE ;
Bozzolo, H ;
Hollway, J ;
Cook, A ;
DiSilvestro, RA ;
Bozzolo, DR ;
Crowl, L ;
Ramadan, Y ;
Williams, C .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (04) :628-636
[6]  
Aronson M, 1997, DEV MED CHILD NEUROL, V39, P583
[7]   Exanthematic diseases during pregnancy and attention-deficit/hyperactivity disorder (ADHD) [J].
Arpino, C ;
Marzio, M ;
D'Argenzio, L ;
Longo, B ;
Curatolo, P .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2005, 9 (05) :363-365
[8]   Cytogenetic abnormalities in attention-deficit/hyperactivity disorder [J].
Bastain, TM ;
Lewczyk, CM ;
Sharp, WS ;
James, RS ;
Long, RT ;
Eagen, PB ;
Ebens, CL ;
Meck, JM ;
Chan, WY ;
Sidransky, E ;
Rapoport, JL ;
Castellanos, EX .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (07) :806-810
[9]  
Biederman J, 2002, J Atten Disord, V6 Suppl 1, pS7
[10]   FAMILY-GENETIC AND PSYCHOSOCIAL RISK-FACTORS IN DSM-III ATTENTION DEFICIT DISORDER [J].
BIEDERMAN, J ;
FARAONE, SV ;
KEENAN, K ;
KNEE, D ;
TSUANG, MT .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1990, 29 (04) :526-533